BioNTech SE
BNTX
$99.47
$2.012.06%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -500.78M | -543.77M | 118.45M | 999.08M | 2.83B |
| Total Depreciation and Amortization | 228.93M | 225.07M | 206.09M | 198.18M | 142.98M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 712.41M | 906.23M | 711.51M | -352.82M | -1.57B |
| Change in Net Operating Assets | 1.18B | 2.62B | 5.19B | 5.00B | 4.37B |
| Cash from Operations | 1.62B | 3.21B | 6.23B | 5.85B | 5.78B |
| Capital Expenditure | -329.01M | -307.75M | -285.54M | -270.50M | -319.97M |
| Sale of Property, Plant, and Equipment | 545.10K | 215.30K | -- | -- | 204.40K |
| Cash Acquisitions | 0.00 | -366.69M | -366.69M | -366.69M | -366.69M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.49B | -6.33B | -8.59B | -6.89B | -4.10B |
| Cash from Investing | -5.82B | -7.00B | -9.24B | -7.53B | -4.79B |
| Total Debt Issued | 200.00K | 300.00K | 300.00K | 300.00K | 300.00K |
| Total Debt Repaid | -50.90M | -52.40M | -38.90M | -40.40M | -37.30M |
| Issuance of Common Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Common Stock | -800.00K | -302.50M | -456.50M | -738.50M | -793.40M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Financing | -55.69M | -385.50M | -538.71M | -842.64M | -894.86M |
| Foreign Exchange rate Adjustments | -149.20M | -80.06M | 22.76M | -13.69M | -18.08M |
| Miscellaneous Cash Flow Adjustments | 194.09M | 151.10M | 107.51M | 177.42M | -510.90K |
| Net Change in Cash | -4.21B | -4.11B | -3.42B | -2.36B | 76.25M |
